Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版

Ahead of print
Authors' Accepted
Current Issue
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us

Resources & Services

Email alert

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the

AJA Club (in English)
AJA Club (in Chinese)


Volume 11, Issue 1 (January 2009) 11, 28–35; 10.1038/aja.2008.39

Stroma-epithelium crosstalk in prostate cancer

Yi-Nong Niu1 and Shu-Jie Xia2

1 Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
2 Department of Urology, Shanghai First People’s Hospital, Shanghai Jiao Tong University, Shanghai 200080, China

Correspondence: Prof. Shu-Jie Xia, Department of Urology, Shanghai First People’s Hospital, Shanghai Jiao Tong University, Shanghai 200080, China. Fax: +86-21-6324-1377 E-mail: xsjurologist@163.com

Received 29 October 2008; Accepted 30 October 2008; Published online 22 December 2008


The critical role played by stroma–epithelium crosstalk in carcinogenesis and progression of prostate cancer has been increasingly recognized. These interactions are mediated by a variety of paracrine factors secreted by cancer cells and/or stromal cells. In human prostate cancer, reactive stroma is characterized by an increase in myofibroblasts and a corresponding amplification of extracellular matrix production and angiogenesis. Permanent genetic mutations have been reported in stromal cells as well as in tumour cells. Transforming growth factor-, vascular endothelial growth factor, platelet-derived growth factor and fibroblast growth factor signalling pathways are involved in the process of angiogenesis, whereas hepatocyte growth factor, insulin-like growth factor-1, epidermal growth factor, CXC12 and Interleukin-6 play active roles in the progression, androgen-independent conversion and distal metastasis of prostate cancer. Some soluble factors have reciprocal interactions with androgens and the androgen receptor (AR), and can even activate AR in the absence of the androgen ligand. In this article, we review the complex interactions between cancer cells and the surrounding microenvironment, and discuss the potential therapeutic targets in the stromal compartment of prostate cancer.

Keywords: angiogenesis, metastasis, paracrine growth factors, prostate, prostatic neoplasm, stroma

PDF | PDF | 中文摘要 |

Browse:  4439
Copyright 1999-2017  Shanghai Materia Medica, Shanghai Jiao Tong University.  All rights reserved